Absolute contraindication for combined oral contraceptive pill.

Question

09 Jan 2025

Answer :

Word Count : 569

Combined oral contraceptive pills (COCPs) are widely used for contraception and offer additional benefits, such as regulation of menstrual cycles and reduction in the risk of certain cancers. However, they are contraindicated in specific medical conditions where their use could result in significant harm. These contraindications are classified as "absolute" when the risks of COCPs outweigh any potential benefits.

### 1. Cardiovascular Disorders
- History of Thromboembolism: COCPs increase the risk of blood clot formation. Women with a history of deep vein thrombosis (DVT) or pulmonary embolism (PE) are at high risk of recurrence.
- Stroke or Ischemic Heart Disease: Individuals with a history of stroke or myocardial infarction are at increased risk due to the prothrombotic effects of COCPs.
- Uncontrolled Hypertension: Blood pressure above 160/100 mmHg significantly elevates the risk of stroke or cardiovascular _______ _________ ____ ______ _______ ______.
______ ___ _____ ______ _______ _____ ________ ___ ___ _____.
___ _________ ____ _________ ____.
__________ ______ ___ _______ ________ ____ _____ ______ ______ ____.
__________ __________ __________ __________ _________ ___ _______ ____ ________ ____ ____ _________.
_______ ____ _____ _______ ___ _________ _______ ____ ___.
______ _______ _________ ______ _________ _____ ___ _____ _____ _____ ______.
___ ____ __________ _______ ___ ____ ________ ____ ________ ______.
_____ _____ __________ ____ __________.
______ _____ _____ _______ ______ _________ ______ _________ _______ _____ _________.
________ ____ _______ _______ ___ ________ _______ ________ _______.
___ _______ __________ _____ ______.
_____ _______ ______ ______ __________ ____.
__________ __________ _______ _________ _______ __________.
_________ ___ ____ ______ ____ ______ ________ ______ ___ ___ _____ _____.
__________ _______ ___ ___ ________ ________ ________ __________ _________ ________ _______.
__________ _______ __________ ____ ______ ___ ___ __________.
___ __________ ________ ____ ________.
_____ __________ _____ _____ _____ _________ _________ _______ __________.
__________ ____ _______ _______ _______ _________ _________ _________ ______ __________ _________.
___ ___ ____ ___ _________ ______ __________ ____ _________.
_____ _____ __________ ________ ________ _________ ________ _________ ______.
_____ ____ ____ __________ ______ __________.
____ _____ ____ _____ ________ _________ _______ ___ ________ _________.
__________ ________ ____ ___ ______ _________ ___ ___ ________ _____.
____ __________ __________ ___ ____ ______ _________ _________ ________ _____ ____ __________.
________ _______ _______ _________ __________ _________ ______ _________ _________.
_____ _____ __________ _______ _______ ______.
_________ ________ _________ ___ ______ _________ ___.
___ ____ _____ _______ ________ ___ ___ _____ __________ ____.
_________ _________ ________ _____ ___.
_____ ____ _________ __________ ___ ____ __________ __________ ______.
_______ ___ _______ _________ _________ _______ ________ _________ ______.
_______ _____ ______ __________ __________ _______.
__________ _________ _______ __________ ________ __________ ____ _________ ______.
______ ________ ______ _________ ________ _____ __________ ___ _______ _________.
___ ___ __________ ____ ____ ________ __________ _____ ______ ________ ____ ______.
_____ _________ ______ ___ __________ _________ ___ _________ _________.
_______ ____ _________ __________ _________ _______ ______.
__________ ____ ______ ____ _____ ____ _______ _____ ______ _____ _____.
_____ _______ _______ _____ ______ _____ ____ ________ ___ _______ ________.
__________ ________ ________ __________ ________ ____ ___ _______.
_________ __________ ____ _________ ____ _________ ____ ________ _______.
_________ ___ ______ ________ ___ __________ ______ _______ _______ ___ __________.
_________ _____ __________ _______ ____ __________ ______ _______ ______ ___.
__________ __________ ________ _____ ______ ___ ______ ________ _________ _____ ________.
_________ ________ _________ _____ _________ ______ ___ ___ _____ ___ ____.
________ _________ __________ ________ ______.
________ __________ ____ _______ ______.
Get Full Answer on WhatsApp

IGNOU Solved Assignments Assignments Ignou Projects Project Previous Year Solved Exam Papers Notes Notes Sample Question Papers Sample Question Papers

IGNOU NEWS

Assignment Submission Last Date Extended Till 30 June 2026 Click Here★★★IGNOU June 2026 TEE Date Sheet Released Click Here★★★